TTrialPathMatch Me to Trials
← Back to trials
RecruitingDiabetes Mellitus Type 2, Childhood-Onset

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Eligible age

8–15 yrs

Accepts

All genders

Locations

14 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.

Sponsor: George Washington University

You may qualify if…

  • Screening will occur to enrich the yield of individuals who are highly predisposed to develop youth-onset T2D and include those with all of the following criteria:
  • Overweight or obesity with BMI ≥85th percentile
  • Age 8-13 year for girls, 9-15 year for boys (inclusion younger for girls as puberty tends to start a year earlier in girls)
  • Tanner Stage 2, 3, or 4
  • Elevated HbA1c 5.5-6.4%

You may not qualify if…

  • An individual who meets any of the following criteria will be excluded from participation:
  • Diabetes based on history, or HbA1c ≥6.5% in the medical record or at screening
  • Unable/unwilling to provide consent/participate fully
  • Conditions predisposing to diabetes or altering the trajectory of puberty
  • Medications affecting glucose dynamics during the screening and enrollment period
  • Prior treatment with insulin
  • Use of glucagon-like peptide-1 (GLP-1) receptor agonist or any weight loss medications in the 6 weeks prior to enrollment
  • Planning treatment with glucagon-like peptide-1 (GLP-1) receptor agonist or any weight loss medications

Where it's recruiting

Alabama

Birmingham

Arizona

Phoenix

California

Los Angeles

Colorado

Aurora

Florida

St. Petersburg

Maryland

Baltimore

New Mexico

Shiprock

New York

Brooklyn · Garden City · New York · The Bronx

North Carolina

Charlotte · Winston-Salem

Ohio

Cincinnati · Columbus

Oklahoma

Oklahoma City

Source: ClinicalTrials.gov · NCT06525259 · last updated 2026-05-07